03/28/2025
3:30 PM | GSK plc (Filed by)
Spero Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/27/2025
4:19 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
3:30 PM | Spero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2025
4:11 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:04 PM | Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:52 PM | Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:30 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:31 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:00 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:37 PM | Anson Funds Management LP (Filed by)
Spero Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:02 PM | Spero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
4:01 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:56 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
5:36 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:42 PM | Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:43 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:56 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy SPRO Stock Free SPRO Stock Alerts